These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 15507213

  • 21. Mechanisms controlling pathogenesis and survival of leukemic stem cells.
    Jordan CT, Guzman ML.
    Oncogene; 2004 Sep 20; 23(43):7178-87. PubMed ID: 15378078
    [Abstract] [Full Text] [Related]

  • 22. Shp2 function in hematopoietic stem cell biology and leukemogenesis.
    Nabinger SC, Chan RJ.
    Curr Opin Hematol; 2012 Jul 20; 19(4):273-9. PubMed ID: 22504523
    [Abstract] [Full Text] [Related]

  • 23. Rac2-deficient hematopoietic stem cells show defective interaction with the hematopoietic microenvironment and long-term engraftment failure.
    Jansen M, Yang FC, Cancelas JA, Bailey JR, Williams DA.
    Stem Cells; 2005 Mar 20; 23(3):335-46. PubMed ID: 15749928
    [Abstract] [Full Text] [Related]

  • 24. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.
    Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, Wu H, Li L.
    Nature; 2006 May 25; 441(7092):518-22. PubMed ID: 16633340
    [Abstract] [Full Text] [Related]

  • 25. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Steidl U, Rosenbauer F, Verhaak RG, Gu X, Ebralidze A, Otu HH, Klippel S, Steidl C, Bruns I, Costa DB, Wagner K, Aivado M, Kobbe G, Valk PJ, Passegué E, Libermann TA, Delwel R, Tenen DG.
    Nat Genet; 2006 Nov 25; 38(11):1269-77. PubMed ID: 17041602
    [Abstract] [Full Text] [Related]

  • 26. Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice.
    Drutskaya MS, Ortiz M, Liepinsh DJ, Kuprash DV, Nedospasov SA, Keller JR.
    Exp Hematol; 2005 Nov 25; 33(11):1348-56. PubMed ID: 16263419
    [Abstract] [Full Text] [Related]

  • 27. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
    Schuringa JJ, Wu K, Morrone G, Moore MA.
    Stem Cells; 2004 Nov 25; 22(7):1191-204. PubMed ID: 15579639
    [Abstract] [Full Text] [Related]

  • 28. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y, Payne KJ, Zhu Y, Price MA, Parrish YK, Zielinska E, Barsky LW, Crooks GM.
    Stem Cells; 2005 Nov 25; 23(6):852-60. PubMed ID: 15917481
    [Abstract] [Full Text] [Related]

  • 29. Rho GTPases and regulation of hematopoietic stem cell localization.
    Williams DA, Zheng Y, Cancelas JA.
    Methods Enzymol; 2008 Nov 25; 439():365-93. PubMed ID: 18374178
    [Abstract] [Full Text] [Related]

  • 30. Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover.
    Brümmendorf TH, Balabanov S.
    Leukemia; 2006 Oct 25; 20(10):1706-16. PubMed ID: 16888616
    [Abstract] [Full Text] [Related]

  • 31. Hematopoietic stem cells, leukemic stem cells and chronic myelogenous leukemia.
    Passegué E.
    Cell Cycle; 2005 Feb 25; 4(2):266-8. PubMed ID: 15655369
    [Abstract] [Full Text] [Related]

  • 32. A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.
    Xu D, Wang S, Yu WM, Chan G, Araki T, Bunting KD, Neel BG, Qu CK.
    Blood; 2010 Nov 04; 116(18):3611-21. PubMed ID: 20651068
    [Abstract] [Full Text] [Related]

  • 33. Distinct requirements of hematopoietic stem cell activity and Nras G12D signaling in different cell types during leukemogenesis.
    Wang J, Liu Y, Tan LX, Lo JC, Du J, Ryu MJ, Ranheim EA, Zhang J.
    Cell Cycle; 2011 Sep 01; 10(17):2836-9. PubMed ID: 21857161
    [Abstract] [Full Text] [Related]

  • 34. The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease.
    Singbrant S, Wall M, Moody J, Karlsson G, Chalk AM, Liddicoat B, Russell MR, Walkley CR, Karlsson S.
    Haematologica; 2014 Apr 01; 99(4):647-55. PubMed ID: 24415629
    [Abstract] [Full Text] [Related]

  • 35. Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice.
    Ishida D, Kometani K, Yang H, Kakugawa K, Masuda K, Iwai K, Suzuki M, Itohara S, Nakahata T, Hiai H, Kawamoto H, Hattori M, Minato N.
    Cancer Cell; 2003 Jul 01; 4(1):55-65. PubMed ID: 12892713
    [Abstract] [Full Text] [Related]

  • 36. Rheb1 loss leads to increased hematopoietic stem cell proliferation and myeloid-biased differentiation in vivo.
    Wang X, Gao Y, Gao J, Li M, Zhou M, Wang J, Pang Y, Cheng H, Yuan C, Chu Y, Jiang Y, Zhou J, Luo HR, Ju Z, Cheng T, Yuan W.
    Haematologica; 2019 Feb 01; 104(2):245-255. PubMed ID: 30262562
    [Abstract] [Full Text] [Related]

  • 37. Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells.
    Forsberg EC, Passegué E, Prohaska SS, Wagers AJ, Koeva M, Stuart JM, Weissman IL.
    PLoS One; 2010 Jan 20; 5(1):e8785. PubMed ID: 20098702
    [Abstract] [Full Text] [Related]

  • 38. Life and death in the JUNgle.
    Weitzman JB.
    Trends Mol Med; 2001 Apr 20; 7(4):141-2. PubMed ID: 11286924
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.